Sanctuary Advisors LLC reduced its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 30.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,337 shares of the semiconductor company's stock after selling 3,678 shares during the period. Sanctuary Advisors LLC's holdings in Synopsys were worth $4,388,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Foundations Investment Advisors LLC raised its stake in shares of Synopsys by 2.5% in the 3rd quarter. Foundations Investment Advisors LLC now owns 1,368 shares of the semiconductor company's stock valued at $693,000 after buying an additional 33 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Synopsys by 14.5% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 6,016 shares of the semiconductor company's stock worth $3,046,000 after buying an additional 760 shares in the last quarter. Commerzbank Aktiengesellschaft FI boosted its holdings in Synopsys by 31.1% in the third quarter. Commerzbank Aktiengesellschaft FI now owns 1,032 shares of the semiconductor company's stock valued at $523,000 after acquiring an additional 245 shares during the last quarter. Greenleaf Trust boosted its stake in shares of Synopsys by 19.2% in the 3rd quarter. Greenleaf Trust now owns 6,343 shares of the semiconductor company's stock valued at $3,212,000 after purchasing an additional 1,023 shares during the last quarter. Finally, International Assets Investment Management LLC grew its holdings in Synopsys by 57,616.1% during the 3rd quarter. International Assets Investment Management LLC now owns 239,522 shares of the semiconductor company's stock worth $121,292,000 after acquiring an additional 239,107 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.66% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the company. Piper Sandler lowered their price target on Synopsys from $670.00 to $655.00 and set an "overweight" rating for the company in a research note on Friday, December 6th. Loop Capital initiated coverage on Synopsys in a research note on Monday, November 11th. They set a "buy" rating and a $675.00 price objective on the stock. Wells Fargo & Company reduced their target price on shares of Synopsys from $570.00 to $540.00 and set an "equal weight" rating for the company in a research note on Monday, January 13th. Robert W. Baird decreased their price objective on Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. Finally, Needham & Company LLC restated a "buy" rating and issued a $640.00 target price on shares of Synopsys in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, Synopsys currently has a consensus rating of "Moderate Buy" and an average target price of $641.82.
Check Out Our Latest Report on SNPS
Synopsys Trading Down 3.9 %
Shares of NASDAQ:SNPS traded down $19.13 on Friday, hitting $474.84. The company had a trading volume of 1,370,372 shares, compared to its average volume of 1,066,749. Synopsys, Inc. has a 1-year low of $457.52 and a 1-year high of $629.38. The stock has a market cap of $73.40 billion, a price-to-earnings ratio of 32.70, a P/E/G ratio of 3.28 and a beta of 1.12. The stock has a 50 day moving average price of $510.88 and a 200 day moving average price of $517.44.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
